Novel human cancer cell-line genomic model using CRISPR/Cas9 for assessing methotrexate pharmacogenomics: MiSSK study - Phase I
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI